| First Author | Lu Y | Year | 2021 |
| Journal | Nat Cell Biol | Volume | 23 |
| Issue | 10 | Pages | 1060-1072 |
| PubMed ID | 34616019 | Mgi Jnum | J:318598 |
| Mgi Id | MGI:6860483 | Doi | 10.1038/s41556-021-00762-2 |
| Citation | Lu Y, et al. (2021) Eosinophil extracellular traps drive asthma progression through neuro-immune signals. Nat Cell Biol 23(10):1060-1072 |
| abstractText | Eosinophilic inflammation is a feature of allergic asthma. Despite mounting evidence showing that chromatin filaments released from neutrophils mediate various diseases, the understanding of extracellular DNA from eosinophils is limited. Here we show that eosinophil extracellular traps (EETs) in bronchoalveolar lavage fluid are associated with the severity of asthma in patients. Functionally, we find that EETs augment goblet-cell hyperplasia, mucus production, infiltration of inflammatory cells and expressions of type 2 cytokines in experimental non-infection-related asthma using both pharmaceutical and genetic approaches. Multiple clinically relevant allergens trigger EET formation at least partially via thymic stromal lymphopoietin in vivo. Mechanically, EETs activate pulmonary neuroendocrine cells via the CCDC25-ILK-PKCalpha-CRTC1 pathway, which is potentiated by eosinophil peroxidase. Subsequently, the pulmonary neuroendocrine cells amplify allergic immune responses via neuropeptides and neurotransmitters. Therapeutically, inhibition of CCDC25 alleviates allergic inflammation. Together, our findings demonstrate a previously unknown role of EETs in integrating immunological and neurological cues to drive asthma progression. |
